Legionella IFA (IF0950) intended for qualitatively detecting and semi-quantitating human serum an...
FDA Device Recall #Z-1685-2017 — Class II — February 15, 2017
Recall Summary
| Recall Number | Z-1685-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 15, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Focus Diagnostics Inc |
| Location | Cypress, CA |
| Product Type | Devices |
| Quantity | 196 units |
Product Description
Legionella IFA (IF0950) intended for qualitatively detecting and semi-quantitating human serum antibodies to Legionella pneumophila.
Reason for Recall
After a submission for CLIA database update from Focus Diagnostics to DiaSorin Molecular,the company found that their Legionella IFA device (IF0950) is not 510(k) exempt.
Distribution Pattern
Product was distributed to three testing laboratories in California, New Jersey and Virginia
Lot / Code Information
Unique Device Identifier IF0950: 20816101020045, lot numbers 30244, 30928, 31288, 31642, 32331, 32562, 32850
Other Recalls from Focus Diagnostics Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1686-2017 | Class II | Legionella IFA Substrate Slide (IF0951) intende... | Feb 15, 2017 |
| Z-1274-2016 | Class I | Simplexa Group A Strep Direct (MOL2850) with Di... | Feb 10, 2016 |
| Z-1272-2016 | Class I | Simplexa HSV 1&2 Direct (MOL2150) with Direct A... | Feb 10, 2016 |
| Z-1273-2016 | Class II | Simplexa Flu A/B & RSV Direct (MOL2650) with Di... | Feb 10, 2016 |
| Z-0238-2016 | Class II | Focus Diagnostics Anaplasma Phagocytophilum IFA... | Oct 2, 2015 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.